Trial Information
Summary: Concerned about bone loss associated with your prostate cancer therapy?
Staten Island Urological Research, PC is conducting a research
study investigating a new medication option for patients at risk of
bone loss associated with prostate cancer therapy.
You may be eligible to participate if you:
- Are a male with confirmed prostate cancer.
- Currently being treated for prostate cancer with androgen
deprivation therapy or have undergone a bilateral orchiectomy.
- Are willing to participate in the full 2 years of the
trial.
Qualified participants will receive study-related
investigational medication, examinations and laboratory tests at no
cost. Participants will be reimbursed for their time and travel
expenses.
For more information,
|
Contact:
Maureen Lampo, PA-C
Staten Island Urological Research, PC
1800 Clove Road
Staten Island, NY 10304
Telephone: 718-720-6040
Fax: 718-720-6523
Email:
|
|

If you would like to learn more about participating in this study, please send an e-mail message using the form below.
Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.
This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.
Trial listings updated: June 1, 2008 at 5:44:19 AM